Clinical Trial: A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738614) titled 'A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight' on July 28.

Brief Summary: The main purpose of this study is to find out how significantly Eloralintide slows stomach emptying in participants who are overweight or obese. For each participant, the study will last approximately 21 weeks and will include 2 overnight stays in the clinical research unit (CRU) lasting between 4 and 8 days. There will be 13 other visits.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Obesity Overweight

Intervention: DRUG: Eloralintide

Administered SC

DRUG: Placebo

Administered SC

DRUG: Acetaminoph...